(Q40620043)

22 September 2017

A dengue virus serotype-1 DNA vaccine induces virus neutralizing antibodies and provides protection from viral challenge in Aotus monkeys (English)

1 reference

22 September 2017

0 references

Kochel TJ

1

1 reference

22 September 2017

Raviprakash K

2

1 reference

22 September 2017

Hayes CG

3

1 reference

22 September 2017

Watts DM

4

1 reference

22 September 2017

Russell KL

5

1 reference

22 September 2017

Gozalo AS

6

1 reference

22 September 2017

Phillips IA

7

1 reference

22 September 2017

Ewing DF

8

1 reference

22 September 2017

Murphy GS

9

1 reference

22 September 2017

Porter KR

10

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 July 2000

1 reference

22 September 2017

1 reference

22 September 2017

18

1 reference

22 September 2017

27

1 reference

22 September 2017

3166-3173

1 reference

Flavivirus genome organization, expression, and replication

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900105-5

7 January 2021

Pathogenesis of dengue: challenges to molecular biology

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900105-5

7 January 2021

Japanese encephalitis and dengue vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900105-5

7 January 2021

Yellow fever vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900105-5

7 January 2021

A live attenuated dengue-1 vaccine candidate (45AZ5) passaged in primary dog kidney cell culture is attenuated and immunogenic for humans

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900105-5

7 January 2021

Lack of attenuation of a candidate dengue 1 vaccine (45AZ5) in human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900105-5

7 January 2021

Immunization of monkeys with baculovirus-dengue type-4 recombinants containing envelope and nonstructural proteins: evidence of priming and partial protection.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900105-5

7 January 2021

Dengue 2 Virus Envelope Protein Expressed by a Recombinant Vaccinia Virus Fails to Protect Monkeys against Dengue

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900105-5

7 January 2021

Protective efficacy of a dengue 2 DNA vaccine in mice and the effect of CpG immuno-stimulatory motifs on antibody responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900105-5

7 January 2021

DNA-based and alphavirus-vectored immunisation with prM and E proteins elicits long-lived and protective immunity against the flavivirus, Murray Valley encephalitis virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900105-5

7 January 2021

Immunisation with DNA polynucleotides protects mice against lethal challenge with St. Louis encephalitis virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900105-5

7 January 2021

Naked DNA vaccines expressing the prM and E genes of Russian spring summer encephalitis virus and Central European encephalitis virus protect mice from homologous and heterologous challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900105-5

7 January 2021

Induction of protective immunity against Japanese encephalitis in mice by immunization with a plasmid encoding Japanese encephalitis virus premembrane and envelope genes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900105-5

7 January 2021

The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900105-5

7 January 2021

Immunogenicity of dengue virus type 1 DNA vaccines expressing truncated and full length envelope protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900105-5

7 January 2021

Evaluation of vero cell lysate antigen for the ELISA of flaviviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900105-5

7 January 2021

Malaria DNA vaccines in Aotus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900105-5

7 January 2021

CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900105-5

7 January 2021

Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900105-5

7 January 2021

DNA vaccination: transfection and activation of dendritic cells as key events for immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900105-5

7 January 2021

Dengue-2 vaccine: viremia and immune responses in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900105-5

7 January 2021

Monkeys immunized with intertypic chimeric dengue viruses are protected against wild-type virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900105-5

7 January 2021

Cross-protection studies and search for subclinical disease in new world monkeys infected sequentially with different immunologic types of Dengue viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900105-5

7 January 2021

10.1016/S0264-410X(00)00105-5

Identifiers

DOI

1 reference

22 September 2017

1 reference